Literature DB >> 417018

Free light chain synthesis by neoplastic cells in chronic lymphocytic leukaemia and non-Hodgkin's lymphoma.

J Gordon, A R Howlett, J L Smith.   

Abstract

Cell populations from twenty-two cases of B-cell neoplasia reflecting various stages of B-lymphocyte maturation were investigated for their ability to synthesise immunoglobulin (Ig) in vitro. All surface Ig positive neoplasms studied synthesised labelled Ig of the same light chain class as that expressed at the cell surface. Immature B-cell neoplasms, chronic lymphocytic leukaemia (CLL) and CLL-type lymphoma, synthesised only a minor proportion of their total protein as Ig; labelled free light chain was the only detectable secreted Ig product in thirteen cases and was in excess in the remaining four. Labelled heavy chain was detected in cell lysates in all but one case. Follicular centre cell lymphomas, neoplasms of more mature B-lymphocyte types, synthesised more of their total protein as Ig and showed a more balanced synthesis of heavy and light chains compared to the other neoplasms studies. The Ig synthesis patterns and, in particular, free light chain production, are discussed in relation to normal B-lymphocyte maturation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 417018      PMCID: PMC1457609     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.

Authors:  S V Payne; D B Jones; D G Haegert; J L Smith; D H Wright
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

2.  Further studies of the gamma-related proteins of normal urine.

Authors:  G T STEVENSON
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

3.  B-cell neoplasia in man.

Authors:  S E Salmon; M Seligmann
Journal:  Lancet       Date:  1974-11-23       Impact factor: 79.321

4.  Relative rates of synthesis of immunoglobulins and light chains in rabbit spleen cells during secondary response.

Authors:  V T Skvortsov; A E Gurvich
Journal:  Nature       Date:  1968-04-27       Impact factor: 49.962

5.  Urinary light chain excretion in leukaemia and lymphoma.

Authors:  F D Lindström; R C Williams; A Theologides
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

Review 6.  The identification of mouse myeloma cells which have undergone mutations in immunoglobulin production.

Authors:  S L Morrison; R Baumal; B K Birshtein; U M Kuehl; J L Preud'homme; L Frank; T Jasek; M D Scharff
Journal:  Soc Gen Physiol Ser       Date:  1974

7.  Immunoglobulin expression and synthesis by human haemic cell lines.

Authors:  J Gordon; D Hough; A Karpas; J L Smith
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

8.  Light and heavy chain components of gamma globulins in urines of normal persons and patients with agammaglobulinemia.

Authors:  J H Vaughan; R F Jacox; B A Gray
Journal:  J Clin Invest       Date:  1967-02       Impact factor: 14.808

9.  Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin.

Authors:  V C Maino; J T Kurnick; R T Kubo; H M Grey
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

10.  Occurrence of surface IgM, IgD, and free light chains of human lymphocytes.

Authors:  S M Fu; R J Winchester; H G Kunkel
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

View more
  16 in total

1.  Free immunoglobulin light chain synthesis by lymphocytes from patients with hypogammaglobulinaemia.

Authors:  J Gordon; J L Smith
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

2.  Biosynthesis and characterisation of IgMlambda in a case of chronic lymphocytic leukaemia with intracellular immunoglobulin inclusions.

Authors:  G H Roberts; J Gordon; J L Smith; D Newell; R Pike
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

3.  Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.

Authors:  M Abe; T Goto; M Kosaka; D Wolfenbarger; D T Weiss; A Solomon
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  Urinary monoclonal free light chains in primary Sjögren's syndrome: an aid to the diagnosis of malignant lymphoma.

Authors:  M T Walters; F K Stevenson; A Herbert; M I Cawley; J L Smith
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103

5.  Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia.

Authors:  Matthew J Maurer; James R Cerhan; Jerry A Katzmann; Brian K Link; Cristine Allmer; Clive S Zent; Timothy G Call; Kari G Rabe; Curtis A Hanson; Neil E Kay; Susan L Slager; Thomas E Witzig; Tait D Shanafelt
Journal:  Blood       Date:  2011-07-15       Impact factor: 22.113

6.  Detection of free kappa chains in human serum and urine using pairs of monoclonal antibodies reacting with C kappa epitopes not available on whole immunoglobulins.

Authors:  N R Ling; J Lowe; D Hardie; S Evans; R Jefferis
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

7.  Free immunoglobulin light chain synthesis by human foetal liver and cord blood lymphocytes.

Authors:  A C Hannam-Harris; J L Smith
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

8.  Immunoglobulin synthesis by neoplastic cells: models of a clonal transition from IgM to IgG synthesis.

Authors:  J Gordon; J L Smith
Journal:  J Clin Pathol       Date:  1980-06       Impact factor: 3.411

9.  Reactive and neoplastic human lymphoid cells producing J chain in the absence of immunoglobulin: evidence for the existence of 'J chain disease'?

Authors:  D Y Mason; H Stein
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

10.  Histochemical studies for 5'-nucleotidase and alpha-naphthyl (non-specific) esterase in lymphocytes from patients with primary immunoglobulin deficiencies.

Authors:  N Matamoros; D A Horwitz; C Newton; G L Asherson; A D Webster
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.